Clinical Trial Update: The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy of a dentifrice (Sensodyne) from GlaxoSmithKline in providing immediate and short-term relief from dentin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Sensodyne

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dentine Hypersensitivity | Phase 3 | Status: COMPLETED | Results posted: 2017-04-18